We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00714311
First Posted: July 14, 2008
Last Update Posted: February 16, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
doerings, University Hospital Muenster
Results First Submitted: February 4, 2015  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single (Outcomes Assessor);   Primary Purpose: Treatment
Condition: Borderline Personality Disorder
Interventions: Behavioral: Transference-Focused Psychotherapy
Behavioral: treatment by experienced community psychotherapists

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Transferenced-Focused Psychotherapy Transferenced-Focused Psychotherapy (TFP)
Experienced Community Psychotherapists Experienced Community Psychotherapists (ECP)

Participant Flow:   Overall Study
    Transferenced-Focused Psychotherapy   Experienced Community Psychotherapists
STARTED   52   52 
COMPLETED   39   30 
NOT COMPLETED   13   22 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Transferenced-Focused Psychotherapy Transferenced-Focused Psychotherapy (TFP)
Experienced Community Psychotherapists Experienced Community Psychotherapists (ECP)
Total Total of all reporting groups

Baseline Measures
   Transferenced-Focused Psychotherapy   Experienced Community Psychotherapists   Total 
Overall Participants Analyzed 
[Units: Participants]
 52   52   104 
Age 
[Units: Participants]
     
<=18 years   0   0   0 
Between 18 and 65 years   52   52   104 
>=65 years   0   0   0 
Age 
[Units: Years]
Mean (Standard Deviation)
 27.46  (6.8)   27.19  (7.5)   27.33  (7.11) 
Gender 
[Units: Participants]
     
Female   52   52   104 
Male   0   0   0 
Region of Enrollment 
[Units: Participants]
     
Austria   20   20   40 
Germany   32   32   64 


  Outcome Measures

1.  Primary:   Drop-out   [ Time Frame: 1 year ]

2.  Primary:   Suicidality (Suicide Attempts)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

3.  Secondary:   Psychosocial Functioning (Global Assessment of Functioning, GAF-Score)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

4.  Secondary:   Level of Personality Organization (Structured Interview for Personality Organization, STIPO)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

5.  Secondary:   Number of Self-harming Acts   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

6.  Secondary:   Self-assessment of Psychopathology (BDI, STAI, BSI)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

7.  Secondary:   Attachment Style and Reflective Function (Adult Attachment Interview, AAI)   [ Time Frame: 1 year ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

8.  Secondary:   Borderline Symptomatology (DSM-IV Criteria)   [ Time Frame: 1 month ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Stephan Doering
Organization: Medical University of Vienna
phone: +43140400 ext 25190
e-mail: stephan.doering@meduniwien.ac.at


Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: doerings, University Hospital Muenster
ClinicalTrials.gov Identifier: NCT00714311     History of Changes
Other Study ID Numbers: 1106/04
10636
DPG0802
First Submitted: July 9, 2008
First Posted: July 14, 2008
Results First Submitted: February 4, 2015
Results First Posted: February 16, 2015
Last Update Posted: February 16, 2015